Don't miss out on our free whitepaper resource: Conventional versus Convenience: Clinician Collected or At-Home Collected Testing for Sexually Transmitted Infections!

Download the whitepaper here: bit.ly/48JIec0

The U.S. National Institutes of Health (NIH) has named Dr. Jeanne Marrazzo as Dr. Anthony Fauci’s full-time replacement as the head of the National Institute of Allergy and Infectious Diseases (NIAID).
labpulse.com/business-insig…

Molecular diagnostics company Co-Diagnostics is to receive over $2 million from the Bill & Melinda Gates Foundation toward completion of tuberculosis (TB) and human papillomavirus (HPV) tests for the company's Co-Dx PCR Home platform.
labpulse.com/research-and-d…

Illumina has struck a deal to make Pillar Biosciences’ oncology assets commercially available globally as part of its own portfolio.
labpulse.com/business-insig…

Cumulus Neuroscience is joining with two U.K. universities -- Bath and Bristol -- on the development of a test for cognition with potential as an early diagnosis tool in Alzheimer’s dementia.
labpulse.com/diseases/healt…

The U.S. Food and Drug Administration (FDA) has started a one-year pilot program to help reduce the risks associated with laboratory developed oncology tests.
labpulse.com/business-insig…

ApoB tests may reveal risk of heart disease missed by #cholesterol tests
buff.ly/3rF4OkS via LabPulse #cardiovascular

New scanning method creates whole-body “atlases” of biological systems #NBTintheNews via LabPulse labpulse.com/diagnostic-tec…

The Association for Molecular Pathology (AMP) and other bodies have published recommendations on the inclusion of additional alleles in clinical pharmacogenomic (PGx) genotyping assays.
labpulse.com/diagnostic-tec…

The Association for Molecular Pathology (AMP) and other bodies have published recommendations on the inclusion of additional alleles in clinical pharmacogenomic (PGx) genotyping assays.

labpulse.com/diagnostic-tec…

An analysis of 462 million lipid test results has shown mean total cholesterol levels exceed the target in seven of the 17 studied countries.

labpulse.com/diseases/cardi…

Whole genome sequencing (WGS) is better than a targeted test at identifying abnormalities responsible for genetic disorders in newborns and infants but also costs more and takes longer, according to a study published in JAMA. labpulse.com/diagnostic-tec…

Quest Diagnostics has launched its first consumer-initiated genetic test, Genetic Insights, which is available through its consumer site questhealth.com.
labpulse.com/point-of-care-…

Under the deal, DiamiR will apply the capabilities of JADBio’s Automated Machine Learning (AutoML) bioinformatics platform and services to its own microRNA platform. labpulse.com/15542188

Through the analysis, the researchers identified 69 associations between CpGs and the prevalence of breast cancer, chronic kidney disease, ischemic heart disease, and type 2 diabetes. The majority of the associations had not previously been described. labpulse.com/diagnostic-tec…

Labcorp will pay $19 million as part of a settlement with two whistleblowers who alleged that the firm facilitated kickbacks and violated the False Claims Act. buff.ly/3HLgG9d

The FDA has granted an authorization for the LumiraDx SARS-CoV-2 & Flu A/B RNA Star Complete assay. The test allows for the differentiation of influenza A, influenza B, and SARS-CoV-2 infections within 20 minutes or less. U.S. FDA LumiraDx buff.ly/3I6NM4Z

The FDA granted clearance for the BioFire Spotfire Respiratory Panel. It became the first respiratory panel to test for SARS-CoV-2 that also received a CLIA waiver. buff.ly/3x6tJ0e BioFire Diagnostics (now bioMérieux) U.S. FDA

Long COVID, a post-infection inflammatory syndrome, is significantly impacting the workforce, according to a report published by the New York State Insurance Fund (NYSIF), the state’s largest worker compensation insurance fund. buff.ly/3YB7SKb

A study published in JAMA Network Open found that two vaccines were generally effective over time against severe outcomes from SARS-CoV-2 Omicron infection, but protection among older individuals was more likely to wane six months after the second dose. buff.ly/3EdiOWH